Papillomavirus L2 N-Terminal Peptides for the Induction of Broadly Cross-Neutralizing Antibodies
www.patentreply.ai/tools/patent-expiration/US8404244Important: This calculator does not include patent term extension under 35 U.S.C. § 156, which may apply to certain drug, biologic, animal drug, and medical device patents.
Learn more about PTE and patent expirationPapillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies
Application No. 11883495
May 7, 2029
2y 308d remainingEarliest effective filing
Feb 1, 2006
+ 20 years
Feb 1, 2026
PTA +1191d
May 7, 2029
No TD
—
Final
May 7, 2029
Filing Date
May 13, 2008
Earliest Effective Filing
February 1, 2006
Issue Date
March 26, 2013
PTA
+1191 days
Base Expiry (before PTA)
February 1, 2026
Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.